Skip to content Skip to navigation

Hybrid Graphene Oxide Can Capture and Identify Rare Cell Selectively

Author(s) with affiliations: 

Paresh Ray   (Jackson State University),  DMR-Award # 1205194 

Cancer is known for more than three thousand years, but till in 21st century, it  causes 1 in 8 deaths worldwide.
Recent report demonstarted that aptamer conjugated theranostic graphene oxide based assay has exciting potential for improving cancer diagnosis by detecting CTC from infected blood.
The reported new material  can have enormous potential for real life applications, once it is optimized properly in clinical settings
Original highlight: